Search
Tenax Therapeutics Inc
TENXAdd to Watchlist
12.000USD
+0.130+1.10%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
291.31MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-18The current earnings forecast score of Tenax Therapeutics Inc is 9.00, ranking 16 out of 389 in the Biotechnology & Medical Research industry. The average price target is 23.00, with a high of 30.00 and a low of 14.00.
Analyst Rating
Based on
6
analysts
Strong Buy
Current Rating
35.000
Target Price
+191.67%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
560
Total
5
Median
6
Average
Company name
Ratings
Analysts
Tenax Therapeutics Inc
TENX
6
Ionis Pharmaceuticals Inc
IONS
27
Beigene Ltd
ONC
27
CRISPR Therapeutics AG
CRSP
27
IQVIA Holdings Inc
IQV
26
argenx SE
ARGX
26
1
2
3
...
112
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Tenax Therapeutics Inc's price target?
Analysts forecast that Tenax Therapeutics Inc's price target is USD 23.00, with the highest forecast at USD 30.00 and the lowest forecast at USD 14.00.
How have Tenax Therapeutics IncTENX's recent earnings per share performed?
The market expectation was USD -0.35, while Tenax Therapeutics IncTENX's earnings per share (EPS) for the previous quarter was USD -0.38. EPS for the next quarter is expected at USD -0.38.
What is the analyst rating for Tenax Therapeutics Inc?
Based on the ratings of Tenax Therapeutics Inc's stock from 6 analysts, most analysts support a STRONG BUY trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as STRONG BUY. Please note that this is not trading advice. You still need to conduct your own analysis.
